Structure and Dynamics of PD-L1 and an Ultra-High-Affinity PD-1 Receptor Mutant

Area of Science:

• Immunology
• Structural Biology
• Biochemistry

Background:

• Programmed cell death protein 1 (PD-1) and its ligand PD-L1 are critical regulators of anti-tumor immunity.
• Antibodies targeting the PD-1/PD-L1 pathway are established cancer immunotherapies.
• Understanding the molecular interactions of PD-1/PD-L1 is crucial for developing improved therapeutics.

Purpose of the Study:

• To elucidate the molecular mechanisms underlying the enhanced binding affinity of a high-affinity consensus (HAC) PD-1 mutant.
• To determine the atomic-scale structure of the HAC PD-1 complex with PD-L1.
• To investigate the role of conformational dynamics and pH in PD-1/PD-L1 interactions.

Main Methods:

• X-ray crystallography to determine the structure of the HAC PD-1/PD-L1 complex.
• Biophysical assays to quantify binding affinity and kinetics.
• Long-timescale molecular dynamics simulations to study protein dynamics and mechanisms of affinity enhancement.
• pH-dependent binding studies.

Main Results:

• The structure reveals that HAC PD-1 binds PD-L1 through a unique network of polar interactions.
• Ten point mutations in HAC PD-1 result in a 35,000-fold increase in binding affinity compared to wild-type PD-1.
• Conformational dynamics play a significant role in the enhanced binding.
• HAC PD-1 exhibits pH-dependent binding, with pseudo-irreversible affinity at low pH, mimicking the tumor microenvironment.

Conclusions:

• The study provides atomic-level insights into the molecular basis of enhanced PD-1/PD-L1 interaction by HAC PD-1.
• The unique binding mode and pH-dependent properties of HAC PD-1 offer potential for next-generation cancer immunotherapies.
• Understanding conformational dynamics is key to designing high-affinity immune checkpoint modulators.